Ignite Creation Date:
2024-05-06 @ 6:15 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05598814
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2022-10-25
Brief Title:
Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks
Sponsor:
Vibeke Backer
Organization:
Rigshospitalet Denmark
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Rhinosinusitis With Nasal Polyps |
| Asthma |
Keywords: